[Mechanism of action of the gastric secretion inhibitor Pirenzepin].
D000109:Acetylcholine / Q000494:pharmacology; D000863:Antacids / Q000494:pharmacology; D000897:Anti-Ulcer Agents / Q000378:metabolism / Q000494:pharmacology*; D001570:Benzodiazepinones / Q000378:metabolism / Q000494:pharmacology*; D001667:Binding, Competitive; D001812:Blood-Brain Barrier; D010437:Peptic Ulcer / Q000188:drug therapy; D010879:Piperazines / Q000378:metabolism / Q000494:pharmacology*; D010890:Pirenzepine; D011970:Receptors, Histamine H2 / Q000187:drug effects; D011976:Receptors, Muscarinic / Q000187:drug effects; D014018:Tissue Distribution
D000863:Antacids; D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D010879:Piperazines; D011970:Receptors, Histamine H2; D011976:Receptors, Muscarinic; D010890:Pirenzepine; D000109:Acetylcholine
Zum Wirkungsmechanismus des Magensekretionshemmers Pirenzepin.